Company news

eXoZymes Inc. news in 2025

eXoZymes Inc.'s news releases, calls and decks from 2025, newest first.

View company

eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion

December 11, 2025

eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today

November 13, 2025

eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff

November 13, 2025

eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

November 10, 2025

CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

October 30, 2025

CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

October 29, 2025

CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference

October 23, 2025

eXoZymes Inc. Partners With B2i Digital to Spotlight the Cell-Free Next Generation of Biomanufacturing

October 14, 2025

Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees

September 30, 2025

eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today

August 12, 2025

eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST

August 7, 2025

eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity

July 29, 2025

eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months

July 22, 2025

eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing

June 26, 2025

eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast

May 16, 2025

eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today

May 12, 2025

eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST

May 7, 2025

eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health

May 6, 2025

Bringing clarity and precision to the cell-free space by introducing exozymes

April 21, 2025

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

April 10, 2025

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

April 2, 2025

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

April 2, 2025

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

March 26, 2025

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

February 21, 2025

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

February 19, 2025

Decks in 2025